Skip to main content
. 2023 May 19;18(5):e0282878. doi: 10.1371/journal.pone.0282878

Table 2. Relative risks associated with hormone therapy compared with model results.

Quantity Reported Value (Confidence Interval) Model Value
Relative risk of hormone therapy by duration of use: 1–4 years 1.05 (1.011–1.089) 1.08
Relative risk of hormone therapy by duration of use: 10–14 years 1.09 (1.003–1.177) 1.24
Relative risk of hormone therapy by time since first use: <5 years 0.99 (0.925–1.055) 1.04
Relative risk of hormone therapy by time since first use: 5–9 years 1.11 (1.042–1.178) 1.14
Relative risk of hormone therapy by time since first use: 10–14 years 1.19 (1.113–1.267) 1.11
Relative risk of hormone therapy by time since first use: 15–19 years 1.22 (1.139–1.301) 1.16
Relative risk of hormone therapy by time since first use: > = 20 years 1.20 (1.125–1.275) 1.10
Relative risk of hormone therapy by time since last use: 1–4 years 1.10 (1.037–1.163) 1.08
Relative risk of hormone therapy by time since last use: 5–9 years 1.01 (0.942–1.078) 1.17
Relative risk of hormone therapy by time since last use: 10–14 years 1.05 (0.966–1.134) 1.17
Relative risk of hormone therapy by time since last use: > = 15 years 1.12 (1.036–1.204) 1.08